Home › Funds › Casdin Capital › BNTX
Casdin Capital position in BNTX
BIONTECH SE · Health Care
Casdin Capital reported holding 85,000 shares of BNTX (BIONTECH SE) in its Q3 2026 13F filing — a position valued at US$8.4M, representing 0.37% of its reported portfolio and ranking #34 among its reported holdings. Casdin Capital first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Casdin Capital's BNTX position evolved
Casdin Capital first disclosed a stake in BNTX in Q3 2026 at 85,000 shares (US$8.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 85.00K | $8.36M | New |
About BNTX and 13F data
BNTX (BIONTECH SE) is a Health Care company. 30 other funds we track also report a position in BNTX — the largest reported positions include Davern Capital Partners, LP (US$67.1M), GSK plc (US$65.7M), Logos Global Management LP (US$63.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BNTX
- Davern Capital Partners, LP 682.15K sh · $67.06M · Q3 2026
- GSK plc 668.53K sh · $65.72M · Q3 2026
- Logos Global Management LP 650.00K sh · $63.90M · Q3 2026
- Long Focus Capital Management, LLC 632.00K sh · $62.13M · Q3 2026
- SAMLYN CAPITAL, LLC 561.70K sh · $55.21M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K sh · $46.20M · Q3 2026
More on Casdin Capital
FAQ
How long has Casdin Capital held BNTX?
Casdin Capital has disclosed BNTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Casdin Capital's current position in BNTX?
As of Q3 2026, Casdin Capital holds 85.00K shares of BNTX (BIONTECH SE), valued at $8.36M, representing 0.37% of its reported portfolio and ranking #34.
Has Casdin Capital been buying or selling BNTX?
In the latest 13F filing (Q3 2026), Casdin Capital newly opened its position in BNTX.
Which other funds hold BNTX?
Other major institutional holders of BNTX include Davern Capital Partners, LP, GSK plc, Logos Global Management LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.